Kaneka Corp (4118):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Kaneka Corp (4118) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12093
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kaneka Corp (Kaneka) is a chemical manufacturing company. Its product offerings include polyvinyl chloride, caustic soda, hydrochloric acid, flexible PVC compounds, rigid PVC compounds, paste PVC and chlorinated PVC. Its products include functional plastics, expandable plastics and products, foodstuffs products, life science products, electronic products and synthetic fibers. It has manufacturing plants in Takasago city, Hyogo; Osaka; Otsu city, Shiga; Kamisu city and Ibaraki. Kaneka operates research laboratories including regenerative medicine and cell therapy laboratories, material solutions new research engine, biotechnology research laboratories and others. The company has operations across Asia, the Americas, Africa, Europe and Oceania. Kaneka is headquartered in Osaka, Japan.

Kaneka Corp (4118) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kaneka Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kaneka Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kaneka Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kaneka Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Kaneka Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kaneka Corp, Medical Equipment, Deal Details 10
Partnerships 10
Kaneka Enters into Licensing Agreement with Med Alliance 10
Cordis Enters into Distribution Agreement with Kaneka 11
Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 12
Kaneka Corp – Key Competitors 13
Kaneka Corp – Key Employees 14
Kaneka Corp – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 16
Recent Developments 17
Product News 17
Oct 06, 2017: Clinical research on regenerative medicine of alveolar bones starts using Kaneka’s closed-circuit cell culture system 17
Other Significant Developments 18
Aug 13, 2018: Kaneka startet offiziell die kontinuierliche Fertigung unter GMP 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Kaneka Corp, Medical Equipment, Key Facts, 2017 2
Kaneka Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Kaneka Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kaneka Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kaneka Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kaneka Corp, Deals By Market, 2012 to YTD 2018 8
Kaneka Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kaneka Enters into Licensing Agreement with Med Alliance 10
Cordis Enters into Distribution Agreement with Kaneka 11
Terumo Enters Into Co-Development Agreement With Kaneka For PTA Balloon Catheters 12
Kaneka Corp, Key Competitors 13
Kaneka Corp, Key Employees 14
Kaneka Corp, Other Locations 15
Kaneka Corp, Subsidiaries 15
Kaneka Corp, Joint Venture 16

List of Figures
Kaneka Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Kaneka Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Kaneka Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Kaneka Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Kaneka Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kaneka Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Kaneka Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kaneka Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Kaneka Corp (4118):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neuraltus Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. It develops macrophage which is based on the recent und …
  • The Walsh Group Ltd:企業の戦略的SWOT分析
    The Walsh Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Royal Orchid Hotels Ltd:企業の戦略・SWOT・財務分析
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tecpetrol SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Tecpetrol SA (Tecpetrol), a subsidiary of Techint Group, is an oil and gas exploration and production company. The company acquires, explores, produces, transports and distributes oil and gas. It operates fields and blocks in Argentina, Venezuela, Bolivia, Ecuador, Mexico, Peru and Colombia. …
  • ethris GmbH-製薬・医療分野:企業M&A・提携分析
    Summary ethris GmbH (Ethris) is a biotechnology company that develops and manufactures therapeutics. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris’ magnetovax is a platform for personalized tumor vacci …
  • Atopix Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • MRF Limited:企業の戦略・SWOT・財務情報
    MRF Limited - Strategy, SWOT and Corporate Finance Report Summary MRF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Fondation MEDINA-製薬・医療分野:企業M&A・提携分析
    Summary Fondation MEDINA (MEDINA) is a research organization that discovers biologically active molecules and drug candidates for unmet medical needs. The organization’s services include access to natural products libraries, drug discovery contract research with its high throughput screening platfor …
  • Tenaska Inc:企業の発電所・SWOT分析2018
    Tenaska Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Opthea Ltd (OPT):企業の財務・戦略的SWOT分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company offers monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed fo …
  • Ana Holdings Inc:企業のM&A・事業提携・投資動向
    Ana Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ana Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • The Walsh Group:企業の戦略・SWOT・財務分析
    The Walsh Group - Strategy, SWOT and Corporate Finance Report Summary The Walsh Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Senvion SA:電力:M&Aディール及び事業提携情報
    Summary Senvion S.A. (Senvion) formerly Senvion S.a.r.l, is a renewable energy company that develops, produces and distributes onshore and offshore wind turbines and towers. It also offers project specific solutions such as turnkey, foundation construction, transport and installation, and service an …
  • HNI Corporation:企業の戦略・SWOT・財務情報
    HNI Corporation - Strategy, SWOT and Corporate Finance Report Summary HNI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Torraspapel, S.A.:企業の戦略的SWOT分析
    Torraspapel, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Gentera SAB de CV (GENTERA):企業の財務・戦略的SWOT分析
    Gentera SAB de CV (GENTERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • RF Surgical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary RF Surgical Systems Inc (RF Surgical Systems), a subsidiary of Medtronic Plc is a medical equipment company that provides retained surgical sponge detection system. The company’s products include RF assure delivery system, RF assure detection system X, and RFDETECT premium. Its RF assures de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆